Anti-Renalase antibody [EPR25655-163]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal Renalase antibody. Suitable for WB, IP and reacts with Human samples.
View Alternative Names
C10orf59, RNLS, Renalase, Monoamine oxidase-C, MAO-C
- IP
Supplier Data
Immunoprecipitation - Anti-Renalase antibody [EPR25655-163] (AB314303)
Renalase was immunoprecipitated from 0.35 mg human kidney tissue lysate with ab314303 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab314303 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution.
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the detection of proteins in the mid-femtogram range.
All lanes:
Immunoprecipitation - Anti-Renalase antibody [EPR25655-163] (ab314303) at 1/1000 dilution
Lane 1:
Human kidney tissue lysate
Lane 2:
ab314303 at 1/30 IP in Human kidney tissue lysate at 10 µg
Lane 3:
Rabbit monoclonal IgG (<a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a>) instead of ab314303 in human kidney tissue lysate at 10 µg
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
true
Exposure time: 119s
- WB
Supplier Data
Western blot - Anti-Renalase antibody [EPR25655-163] (AB314303)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. Low expression : skeletal muscle, heart, lung (PMID : 15841207). This reagent did not detect Renalase in healthy human plasma, but demonstrated a strong band in human kidney. The identity of the higher MW band at approximately 60 kDa (in lane 4) is unknown. In western blot, anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution. Exposure time : Lane 1 : 180 seconds; Lanes 2-5 : 70 seconds.
All lanes:
Western blot - Anti-Renalase antibody [EPR25655-163] (ab314303) at 1/1000 dilution
Lane 1:
Human plasma at 20 µg
Lane 2:
Human kidney tissue lysate at 20 µg
Lane 3:
Human skeletal muscle tissue lysate at 20 µg
Lane 4:
Human heart tissue lysate at 20 µg
Lane 5:
Human lung tissue lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Observed band size: 37 kDa
false
Related conjugates and formulations (1)
-
Anti-Renalase antibody [EPR25655-163] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Renalase impacts the cardiovascular system through its enzymatic function that reduces systemic catecholamine levels. It has been shown the protein interacts with catecholamines beyond the boundaries of a simple enzymatic reaction. Renalase may form complexes with other enzymes that participate in detoxifying catecholamines. Researchers have studied its effects on catecholamine-related stress responses highlighting a potential modulatory function beyond simple substrate degradation.
Pathways
The metabolism of catecholamines involves Renalase in the regulation of the sympathetic nervous system and its associated pathways. Renalase fits into the catecholamine degradation pathway where it works alongside other enzymes such as monoamine oxidase which also breaks down neurotransmitters. These actions influence the broader systemic pathways associated with cardiovascular health by maintaining a balance in neurotransmitter levels and resultant blood pressure regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com